Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific disclosed in a filing yesterday with the US Securities and Exchange Commission the purchase price for its recent acquisitions of Core Informatics and Finesse Solutions, as well as the settlement earlier this year of three patent lawsuits involving DNA sequencing technology from Roche 454 Life Sciences and Illumina.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.